Levels of nasal exhaled hydrogen sulfide in the general population and allergic rhinitis patients. Issue 3 (7th December 2020)
- Record Type:
- Journal Article
- Title:
- Levels of nasal exhaled hydrogen sulfide in the general population and allergic rhinitis patients. Issue 3 (7th December 2020)
- Main Title:
- Levels of nasal exhaled hydrogen sulfide in the general population and allergic rhinitis patients
- Authors:
- Li, Lisha
Liu, Yonglin
Wang, Qiang
Wang, Zixi
Cui, Le
Xu, Yingyang
Guan, Kai - Abstract:
- Abstract: Background: Objective measures used for the differential diagnosis and severity assessment of allergic rhinitis (AR) are still lacking. The involvement of hydrogen sulfide (H2 S) in the development of AR indicates that nasal exhaled H2 S (NeH2 S) has potential as a biomarker to be used in AR patients. This study aimed to evaluate the application value of NeH2 S measurement in the diagnosis and assessment of AR. Methods: This study was a multi‐center cross‐sectional survey conducted in Northwestern China. Demographic information collection and rhinitis assessment were completed through questionnaires. The level of NeH2 S and serum immunoglobulin E were measured. Results: The level of NeH2 S in general population ranged from 0 to 35 ppb, with a median value of 2 ppb. The NeH2 S levels in seasonal allergic rhinitis (SAR) patients were significantly lower than those in general population (2 [1, 2.75] vs. 2 [2, 3] ppb; p = .023), and the NeH2 S value of the SAR group tended to be lower than that of the non‐allergic rhinitis (NAR) group (2 [1, 2.75] vs. 2 [2, 3] ppb; p = .094). The subgroup of AR patients with symptoms lasting longer than 2 weeks per month had a lower NeH2 S level compared with the subgroup of patients with symptoms lasting less than 2 weeks per month (2 [1, 2] vs. 2 [2, 3] ppb; p = .015). Conclusion: This study described the distribution range of NeH2 S levels in the general population. Further study with larger sample size was needed to clarify theAbstract: Background: Objective measures used for the differential diagnosis and severity assessment of allergic rhinitis (AR) are still lacking. The involvement of hydrogen sulfide (H2 S) in the development of AR indicates that nasal exhaled H2 S (NeH2 S) has potential as a biomarker to be used in AR patients. This study aimed to evaluate the application value of NeH2 S measurement in the diagnosis and assessment of AR. Methods: This study was a multi‐center cross‐sectional survey conducted in Northwestern China. Demographic information collection and rhinitis assessment were completed through questionnaires. The level of NeH2 S and serum immunoglobulin E were measured. Results: The level of NeH2 S in general population ranged from 0 to 35 ppb, with a median value of 2 ppb. The NeH2 S levels in seasonal allergic rhinitis (SAR) patients were significantly lower than those in general population (2 [1, 2.75] vs. 2 [2, 3] ppb; p = .023), and the NeH2 S value of the SAR group tended to be lower than that of the non‐allergic rhinitis (NAR) group (2 [1, 2.75] vs. 2 [2, 3] ppb; p = .094). The subgroup of AR patients with symptoms lasting longer than 2 weeks per month had a lower NeH2 S level compared with the subgroup of patients with symptoms lasting less than 2 weeks per month (2 [1, 2] vs. 2 [2, 3] ppb; p = .015). Conclusion: This study described the distribution range of NeH2 S levels in the general population. Further study with larger sample size was needed to clarify the relationship between NeH2 S level and AR. Abstract : This multi‐center cross‐sectional study surveyed the residents in Northwestern China and described for the first time the distribution range of NeH2 S levels in the general population. Our results showed that NeH2 S level of seasonal allergic rhinitis (SAR) patients was significantly lower than that of general population, and the NeH2 S level of the SAR group tended to be lower than that of the non‐allergic rhinitis (NAR) group. … (more)
- Is Part Of:
- Journal of clinical laboratory analysis. Volume 35:Issue 3(2021)
- Journal:
- Journal of clinical laboratory analysis
- Issue:
- Volume 35:Issue 3(2021)
- Issue Display:
- Volume 35, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 35
- Issue:
- 3
- Issue Sort Value:
- 2021-0035-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2020-12-07
- Subjects:
- allergic rhinitis -- biomarker -- diagnosis -- gas signal messenger -- nasal exhaled hydrogen sulfide -- persistence -- severity
Diagnosis, Laboratory -- Periodicals
Medical laboratory technology -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/jcla.23678 ↗
- Languages:
- English
- ISSNs:
- 0887-8013
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.520000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16517.xml